Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
786
-93
-11% -$31.8K 0.05% 313
2026
Q1
$311K Buy
879
+182
+26% +$64.9K 0.06% 272
2025
Q4
$228K Buy
697
+62
+10% +$19.7K 0.07% 261
2025
Q3
$190K Buy
635
+59
+10% +$17.1K 0.06% 295
2025
Q2
$161K Sell
576
-28
-5% -$7.93K 0.06% 288
2025
Q1
$170K Sell
604
-297
-33% -$87.7K 0.07% 255
2024
Q4
$235K Buy
+901
New +$267K 0.15% 159

Other funds holding AMGN

Rossby Financial's AMGN Position: Q2 2026 in Review

Rossby Financial reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $31.8K and leaving 786 shares worth $285K. The position accounts for 0.05% of the portfolio, ranked #313.

Rossby Financial first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $311K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rossby Financial held 786 shares of Amgen worth $285K as of Q2 2026.
  • Rossby Financial sold 93 Amgen shares in Q2 2026, an estimated $31.8K.
  • Amgen made up 0.05% of Rossby Financial's portfolio in Q2 2026, its #313 holding.
  • Rossby Financial first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Rossby Financial's Amgen position peaked at $311K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.